Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapyArmando Santoro, Alexia Bertuzzi, Romano Fabio Lutman et al.|Annals of Oncology|2012Cited by 54
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcomaRita De Sanctis, Armando Santoro, Andrea Marrari et al.|Drug Design Development and Therapy|2015Cited by 41
Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial.Rita De Sanctis, Armando Santoro, Alexia Bertuzzi et al.|PubMed|2015Cited by 18
Superiority of Choi vs Recist Criteria in Evaluating Outcome of Advanced Soft Tissue Sarcoma (STS) Patients Treated with SorafenibRita De Sanctis, Armando Santoro, Milena Gasco et al.|Annals of Oncology|2012Cited by 1